Stability of the transthyretin molecule as a key factor in the interaction with a-beta peptide--relevance in Alzheimer's disease.
Transthyretin (TTR) protects against A-Beta toxicity by binding the peptide thus inhibiting its aggregation. Previous work showed different TTR mutations interact differently with A-Beta, with increasing affinities correlating with decreasing amyloidogenecity of the TTR mutant; this did not impact o...
Guardado en:
Autores principales: | Carlos A Ribeiro, Maria João Saraiva, Isabel Cardoso |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1b2fc98432294093bd439fdd84d1bf51 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A molecular mechanism for transthyretin amyloidogenesis
por: Ai Woon Yee, et al.
Publicado: (2019) -
Epidemiology of variant transthyretin amyloidosis at a reference center in Argentina
por: Maria S. Saez, et al.
Publicado: (2021) -
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells
por: Aubin Michalon, et al.
Publicado: (2021) -
Computational design of new Peptide inhibitors for amyloid Beta (aβ) aggregation in Alzheimer's disease: application of a novel methodology.
por: Gözde Eskici, et al.
Publicado: (2013) -
Mutually stabilizing interactions between proto-peptides and RNA
por: Moran Frenkel-Pinter, et al.
Publicado: (2020)